Living well with
In this section, you’ll find tools, resources and best practice guidance to support you to help your patients live well with myeloma.
Digital Infosession: To transplant or not to transplant – that is the question
In the seventh co-partnered digital infosession from Myeloma UK and UKMS, chaired by Dr Jennifer Travers, clinicians discuss practical approaches to transplant and non-transplant decision making in myeloma, with a focus on shared decision making and real-world case discussion.
Reducing language barriers: Patient Infosheet for your practice
Download a printable infosheet to help people living with myeloma find Myeloma UK support in multiple languages, including via telephone interpretation.
Digital Infosession: Keeping an eye on belantamab mafodotin – mitigating ocular toxicities
In the sixth co-partnered digital infosession from Myeloma UK and UKMS, held on 15 October 2025 and chaired by Dr Jennifer Travers, leading clinicians explored the ocular toxicities associated with belantamab mafodotin (Blenrep®). The session focused on recognising, monitoring and managing eye-related side effects to support safer and more effective treatment delivery.
UKMRA Frailty Group guideline on Assessment and treatment of frail patients living with multiple myeloma
The UK Myeloma Research Alliance Frailty Group has published a new guideline on assessing and treating frailty in people with myeloma.
Other GuidelineDigital Infosession: Frailty and myeloma: the unmet clinical need
In the fifth co-partnered digital infosession from Myeloma UK and UKMS, held on 26 March 2025 and chaired by Professor Guy Pratt, leading clinicians explored the pressing issue of frailty in myeloma patients. The session focused on effective strategies for assessing frailty risk and integrating these practices into everyday clinical care.
Consensus Framework for the Optimal Delivery of Bispecific Antibodies in Multiple Myeloma
Discover the EMMBRAce Project – a UK-wide initiative supporting hospitals in delivering bispecific antibody therapies to multiple myeloma patients. Explore resources, guidance, and educational tools designed to help healthcare providers deliver these life-changing treatments locally.
Digital Infosession: Renal disease in myeloma and related conditions
The fourth co-partnered digital infosession from Myeloma UK and UKMS, held on 16 October 2024 and hosted by Professor Gordon Cook, covers cutting-edge strategies for managing renal complications in myeloma, including myeloma cast nephropathy, paraprotein-related kidney disease, and comprehensive treatment and supportive care approaches.
Digital Infosession: Guidance for managing bone disease and optimal imaging for patients with myeloma
Joining forces once again, Myeloma UK and the UK Myeloma Society (UKMS) proudly present their third co-partnered digital infosession. Chaired by Professor Guy Pratt, this webinar, held on 16 April 2024, brought together top experts for an engaging discussion on effective strategies for managing bone disease in myeloma patients.
Digital Infosession: Effective management of multidisciplinary MGUS and myeloma clinics
Myeloma UK and the UK Myeloma Society (UKMS) are excited to present their second co-partnered digital infosession, chaired by Prof. Guy Pratt. This webinar, recorded on 18 October 2023, features leading experts discussing best practices for managing multidisciplinary clinics, offering valuable guidance for healthcare professionals involved in MGUS and myeloma care.
Digital Infosession: BCMA and GPRC5D antibodies in practice: Implementation and management for healthcare professionals
Myeloma UK and the UK Myeloma Society (UKMS) proudly present their first co-partnered digital infosession. This recording of the live event, held on 19 April 2023, features expert speakers from medicine, nursing, and pharmacy, sharing insights on the innovation journey of these treatments such as bispecific antibodies and offering practical guidance on their implementation and management in clinical practice.
- 1